Penile intraepithelial carcinoma treated with imiquimod 1% in an HIV-positive patient.
Ramoni
Stefano
S
Cusini
Marco
M
Gaiani
Francesca
F
Arancio
Luisa
L
Alessi
Elvio
E
D000287:Administration, Topical; D000634:Aminoquinolines / Q000009:adverse effects / Q000627:therapeutic use*; D019380:Anti-HIV Agents / Q000627:therapeutic use; D002278:Carcinoma in Situ / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D002471:Cell Transformation, Neoplastic / Q000473:pathology*; D003218:Condylomata Acuminata / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D015658:HIV Infections / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D000077271:Imiquimod; D007150:Immunohistochemistry; D008297:Male; D009367:Neoplasm Staging; D010409:Penile Diseases / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D010412:Penile Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D018570:Risk Assessment; D013997:Time Factors; D016896:Treatment Outcome
D000634:Aminoquinolines; D019380:Anti-HIV Agents; D000077271:Imiquimod